23 October 2026 in medRxiv
The incidence distribution of esophageal adenocarcinoma (EAC) and gastroesophageal junction (GEJ) cancers presents important geographic variations, yet the causes of these differences remain unclear. We analyzed 520 whole genomes from EAC/GEJ tumors across eight countries to examine the mutational forces shaping these cancers and their geographic variation. The mutational landscape was highly similar between EAC and GEJ tumors, and was dominated by signatures SBS17a/b, previously associated with reflux in EAC/GEJ. SBS17a/b were linked to obesity in EAC, supporting an indirect role in exacerbating reflux-mediated mutagenesis. Other established risk factors, such as tobacco smoking, did not yield a direct mutational footprint, pointing to non-mutagenic effects in EAC/GEJ. Nonetheless, geographic differences were present, with signatures related to endogenous cellular functions enriched in high-incidence populations. These findings provide new insights into the shared mutational forces that shape EAC and GEJ, as well as their geographic distribution.
23 October 2026 in medRxiv
Approximately half of all pancreatic cancers cannot be explained by known risk factors. Here we present the results of mutational signature analysis in 495 cases of pancreatic cancer from nine countries to explore whether there are previously unknown mutagenic exposures acting on pancreatic cancer genomes. The mutational signature landscape was consistent between countries. We identified one signature not previously found in pancreatic cancer, SBS111, which does not have a confirmed aetiology but is present in >99% of cases and contributes on average 26% of the total mutation burden. No evidence was found for mutational signatures known to be caused by exogenous exposures, nor was any mutational signature capable of explaining differences in incidence rates between countries. These results suggest that the unexplained causes of pancreatic cancer are unlikely to be strongly mutagenic and that non-mutagenic mechanisms may have a prominent role in explaining pancreatic cancer incidence.